Death in connection with treatment with BZ55: 1-butal-3-sulphanilylurea, nadisan.
D006801:Humans; D006967:Hypersensitivity; D007004:Hypoglycemic Agents / Q000009:adverse effects*
D007004:Hypoglycemic Agents
ALLERGY; ANTIDIABETICS/injurious effects